Challenges in CAR T-cell therapy

preview_player
Показать описание
Renier J. Brentjens, MD, PhD, of Memorial Sloan-Kettering Cancer Center, New York, NY, outlines the major challenges in CAR T-cell therapies including remission and relapse rate, cost, as well as mitigating associated toxicities. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
  1. VJHemOnc – Video Journal of Hematology & HemOnc
  2. Speaker: Renier J. Brentjens
  3. Institution: Memorial Sloan Kettering Cancer Center
  4. Event: VJVirtual
  5. Event: SOHO 2020
  6. Format: Interview
Рекомендации по теме
Current challenges in 0:04:22

Current challenges in CAR-T cell therapy and the role of the tumor microenvironment

Challenges in CAR 0:03:12

Challenges in CAR T-cell therapy

The challenges in 0:01:49

The challenges in implementing CAR-T cell therapy for the treatment of solid tumors

Challenges of CAR 0:01:16

Challenges of CAR T-cells in solid tumors

Advancements and challenges 0:02:53

Advancements and challenges in CAR-T cell therapy

Dr. Roboz on 0:01:33

Dr. Roboz on Challenges With CAR T-cell Therapy in ALL

Challenges With CAR 0:01:32

Challenges With CAR T-Cell Therapy

Challenges with CAR 0:01:51

Challenges with CAR T-cell therapy

Dr. Brentjens on 0:01:22

Dr. Brentjens on CAR T-Cell Therapy Challenges

Challenges after CAR 0:01:51

Challenges after CAR T-cell therapy

Dr. Shaughnessy on 0:01:42

Dr. Shaughnessy on Addressing Challenges With CAR T-Cell Therapy in Hematologic Malignancies

The logistical challenges 0:01:58

The logistical challenges of CAR T-cell therapy

Dr. Chaudhary on 0:01:19

Dr. Chaudhary on Remaining Challenges With CAR T-Cell Therapy

CAR-T in solid 0:01:19

CAR-T in solid tumors: challenges and future directions

Regulatory and commercialization 0:01:51

Regulatory and commercialization challenges with CAR T-cell therapy

Challenges associated with 0:01:28

Challenges associated with CAR-T cells in solid tumors

Dr. Maloney on 0:01:17

Dr. Maloney on Challenges With CAR T-Cell Therapy in ALL

#CIRMSymposium: CAR T 0:14:55

#CIRMSymposium: CAR T Cell Therapy Challenges and Lessons Learned - Christine Brown

Overcoming challenges in 0:04:04

Overcoming challenges in CAR T-cell therapy for multiple myeloma

Current challenges with 0:02:47

Current challenges with CAR T-cell therapy

Challenges that CAR-T 0:03:40

Challenges that CAR-T therapy can present to patients

Challenges of CAR 0:01:44

Challenges of CAR T-cell therapy for solid cancers

CAR T-cell therapy: 0:18:33

CAR T-cell therapy: Reprogramming the immune system to treat cancer | Rob Weinkove | TEDxTauranga

Challenges With CAR 0:00:39

Challenges With CAR T-Cell Therapies in AML